Research & Development
Media & Press
Point-of-Care Testing: Page 2
FDA tells consumers to trash tests from company involved in illicit lab scandal
The FDA is unable to confirm how well the tests perform and, as such, there are concerns that the products may not be safe and effective.
August 16, 2023
Quest Diagnostics launches consumer-initiated Alzheimer’s risk assessment test
The new test uses the same technology as Quest's clinical AD-Detect Amyloid Beta 42/40 Ratio biomarker test for assessing amyloid beta protein, a recognized marker for Alzheimer’s, which was made available for physicians in early 2022.
August 1, 2023
PBD receives U.S. patent for phage-based tuberculosis diagnostic kit
PBD is using its expertise in phages to develop Actiphage, a test designed to detect the active mycobacteria that cause tuberculosis in blood samples.
August 1, 2023
Quest Diagnostics launches consumer-initiated genetic test kit
The test uses next-generation sequencing (NGS) technology to analyze thousands of DNA variants in the genes associated with the conditions within the test’s scope, searching more regions in the individual’s genome than microarray testing.
July 12, 2023
SYNLAB to open comprehensive medical care center in Italy
The center within Florence, Italy’s Manifattura Tabacchi will offer a range of routine diagnostics, specialty testing, and medical healthcare services for around 200,000 patients annually.
July 6, 2023
HPV point-of-care test in development combines isothermal amplification, lateral flow detection
A testing platform that combines the two technologies often used separately in diagnostic tests could simplify the equipment and procedures needed for HPV testing.
June 23, 2023
Simple Healthkit at-home testing kits on Walmart.com
The service starts with diagnostic testing -- at-home, in clinics, or at the pharmacy -- and is enabled by reliable tests with fast results, Simple Healthkit said.
June 12, 2023
U.K. funds development of rapid point-of-care test for gonorrhea, chlamydia
University of Birmingham spinout Linear Diagnostics is developing a point-of-care test designed to show if a person is infected with chlamydia or gonorrhea in 20 minutes.
June 8, 2023
Cue Health granted first traditional FDA authorization for at-home test to detect respiratory illness
The Cue COVID-19 Molecular Test detects genetic material from SARS-CoV-2 virus in nasal swabs from adults with signs and symptoms of upper respiratory infection.
June 6, 2023
Domus Diagnostics gets $2.4M NIH grant to develop at-home molecular test
The award, granted as part of the NIH Rapid Acceleration of Diagnostics (RADx) Tech program, will support accelerated validation and scaling of a testing platform to prepare it for a clinical trial.
May 24, 2023
Cepheid announces former Philips executive Vitor Rocha as president
Rocha joins Cepheid after 12 years at Philips, where he was CEO of Philips North America and CEO of its global ultrasound business.
May 23, 2023
Zymo Research, Burst Diagnostics partner to develop, commercialize hand-held diagnostic testing platform
The device leverages a microfluidic cartridge that miniaturizes and integrates steps typically performed in the clinical laboratory setting, including washing and signal amplification, Zymo Research said.
May 18, 2023
Page 2 of 40